Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAGSHIP Study of AQX-1125 After Recent COPD Exacerbation
2013-001951-11Phase 2Completed
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AQX-1125 with Placebo (2 arms). Primary endpoint: Area above the curve for daily EXACT score from baseline to Week 12. Started Jul 2013; status: completed.
02
Drugs
AQX-1125
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-001951-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001951-11.